QDPR

Chr 4AR

quinoid dihydropteridine reductase

Also known as: DHPR, HDHPR, PKU2, SDR33C1

This gene encodes the enzyme dihydropteridine reductase, which catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin. This enzyme is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems. Mutations in this gene resulting in QDPR deficiency include aberrant splicing, amino acid substitutions, insertions, or premature terminations. Dihydropteridine reductase deficiency presents as atypical phenylketonuria due to insufficient production of biopterin, a cofactor for phenylalanine hydroxylase. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 1.061 OMIM phenotype
Clinical SummaryQDPR
🧬
Gene-Disease Validity (ClinGen)
dihydropteridine reductase deficiency · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
64 unique Pathogenic / Likely Pathogenic· 117 VUS of 426 total submissions
📖
GeneReview available — QDPR
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.06LOEUF
pLI 0.000
Z-score 1.42
OE 0.59 (0.341.06)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.28Z-score
OE missense 0.93 (0.811.08)
138 obs / 147.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.59 (0.341.06)
00.351.4
Missense OE?0.93 (0.811.08)
00.61.4
Synonymous OE?0.98
01.21.6
LoF obs/exp: 8 / 13.7Missense obs/exp: 138 / 147.7Syn Z: 0.10
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveQDPR-related hyperphenylalaninemia, BH4-deficient, CLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7327th %ile
GOF
0.5759th %ile
LOF
0.2581th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

426 submitted variants in ClinVar

Classification Summary

Pathogenic34
Likely Pathogenic30
VUS117
Likely Benign171
Benign53
Conflicting7
34
Pathogenic
30
Likely Pathogenic
117
VUS
171
Likely Benign
53
Benign
7
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
20
9
5
0
34
Likely Pathogenic
8
21
1
0
30
VUS
1
96
16
4
117
Likely Benign
0
0
75
96
171
Benign
0
0
49
4
53
Conflicting
7
Total29126146104412

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

45 pathogenic / likely-pathogenic (of 56) ClinVar copy-number / structural variants overlap QDPR — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

QDPR · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →